Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-β Signaling*

Transforming growth factor-β (TGF-β) signaling is controlled by a variety of regulators that target either signaling receptors or activated Smad complexes. Among the negative regulators, Smad7 antagonizes TGF-β signaling mainly through targeting the signaling receptors, whereas SnoN and c-Ski repress signaling at the transcriptional level through inactivation of Smad complexes. We previously found that Arkadia is a positive regulator of TGF-β signaling that induces ubiquitin-dependent degradation of Smad7 through its C-terminal RING domain. We report here that Arkadia induces degradation of SnoN and c-Ski in addition to Smad7. Arkadia interacts with SnoN and c-Ski in their free forms as well as in the forms bound to Smad proteins, and constitutively down-regulates levels of their expression. Arkadia thus appears to effectively enhance TGF-β signaling through simultaneous down-regulation of two distinct types of negative regulators, Smad7 and SnoN/c-Ski, and may play an important role in determining the intensity of TGF-β family signaling in target cells.

[1]  K. Miyazono,et al.  c‐Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[2]  C. Heldin,et al.  TGFβ1-Induced Activation of ATM and p53 Mediates Apoptosis in a Smad7-Dependent Manner , 2006, Cell cycle.

[3]  I. Pot,et al.  Sumoylated SnoN Represses Transcription in a Promoter-specific Manner* , 2006, Journal of Biological Chemistry.

[4]  K. Miyazono,et al.  Nuclear and cytoplasmic c‐Ski differently modulate cellular functions , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[5]  Luzhe Sun,et al.  Dual Role of SnoN in Mammalian Tumorigenesis , 2006, Molecular and Cellular Biology.

[6]  John C. McDermott,et al.  Smad7 Promotes and Enhances Skeletal Muscle Differentiation , 2006, Molecular and Cellular Biology.

[7]  M. Macías-Silva,et al.  SnoN co-repressor binds and represses smad7 gene promoter. , 2006, Biochemical and biophysical research communications.

[8]  K. Miyazono,et al.  Smad Transcriptional Co-Activators and Co-Repressors , 2006 .

[9]  F. Liu,et al.  Repression of Endogenous Smad7 by Ski* , 2004, Journal of Biological Chemistry.

[10]  K. Miyazono,et al.  c-Ski inhibits the TGF-β signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements , 2004, Oncogene.

[11]  M. Kitagawa,et al.  Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[13]  R. Herrmann,et al.  Amplification of SKI is a prognostic marker in early colorectal cancer. , 2004, Neoplasia.

[14]  H. Kuwano,et al.  Increased expression of c‐Ski as a co‐repressor in transforming growth factor‐β signaling correlates with progression of esophageal squamous cell carcinoma , 2004, International journal of cancer.

[15]  Marc Vidal,et al.  Systematic interactome mapping and genetic perturbation analysis of a C. elegans TGF-beta signaling network. , 2004, Molecular cell.

[16]  K. Miyazono,et al.  Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells , 2004, The EMBO journal.

[17]  K. Luo.  Ski and SnoN: negative regulators of TGF-β signaling , 2004 .

[18]  G. Patterson,et al.  DAF-5 is a Ski oncoprotein homolog that functions in a neuronal TGFβ pathway to regulate C. elegans dauer development , 2003, Development.

[19]  Takeshi Imamura,et al.  Arkadia amplifies TGF‐β superfamily signalling through degradation of Smad7 , 2003 .

[20]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[21]  J. Isola,et al.  Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. , 2003, Cancer research.

[22]  Sarah B Tegen,et al.  The Transforming Activity of Ski and SnoN Is Dependent on Their Ability to Repress the Activity of Smad Proteins* , 2003, Journal of Biological Chemistry.

[23]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[24]  K. Miyazono,et al.  Chromosomal Region Maintenance 1 (CRM1)-dependent Nuclear Export of Smad Ubiquitin Regulatory Factor 1 (Smurf1) Is Essential for Negative Regulation of Transforming Growth Factor-β Signaling by Smad7* , 2003, The Journal of Biological Chemistry.

[25]  K. Miyazono,et al.  Two Short Segments of Smad3 Are Important for Specific Interaction of Smad3 with c-Ski and SnoN* 210 , 2003, The Journal of Biological Chemistry.

[26]  K. Miyazono,et al.  Two major Smad pathways in TGF‐β superfamily signalling , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[27]  Yigong Shi,et al.  Structural Mechanism of Smad4 Recognition by the Nuclear Oncoprotein Ski Insights on Ski-Mediated Repression of TGF-β Signaling , 2002, Cell.

[28]  K. Miyazono,et al.  Smurf1 Regulates the Inhibitory Activity of Smad7 by Targeting Smad7 to the Plasma Membrane* 210 , 2002, The Journal of Biological Chemistry.

[29]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[30]  P. Goldschmidt-Clermont,et al.  Deficient Smad7 expression: A putative molecular defect in scleroderma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Ishii,et al.  Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice , 2001, Oncogene.

[32]  M. Kirschner,et al.  The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. , 2001, Molecular cell.

[33]  E. Medrano,et al.  Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling. , 2001, Cancer research.

[34]  J. Wrana,et al.  Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. , 2001, Genes & development.

[35]  S. Ishii,et al.  The Ski Protein Family Is Required for MeCP2-mediated Transcriptional Repression* , 2001, The Journal of Biological Chemistry.

[36]  N. Nomura,et al.  SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. , 2001, Biochemical and biophysical research communications.

[37]  J. Wrana,et al.  TGF-β induces assembly of a Smad2–Smurf2 ubiquitin ligase complex that targets SnoN for degradation , 2001, Nature Cell Biology.

[38]  Tomoki Chiba,et al.  Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.

[39]  R. Arkell,et al.  Induction of the mammalian node requires Arkadia function in the extraembryonic lineages , 2001, Nature.

[40]  J. Walsh,et al.  Arkadia enhances nodal-related signalling to induce mesendoderm , 2001, Nature.

[41]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[42]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[43]  J. Campisi,et al.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Ishii,et al.  The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice , 2000, The EMBO journal.

[45]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[46]  J. Wrana,et al.  Smads as transcriptional co-modulators. , 2000, Current opinion in cell biology.

[47]  K. Miyazono,et al.  c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads* , 1999, The Journal of Biological Chemistry.

[48]  R. Weinberg,et al.  SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[49]  K. Luo,et al.  Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein , 1999 .

[50]  K. Miyazono,et al.  E1A Inhibits Transforming Growth Factor-β Signaling through Binding to Smad Proteins* 210 , 1999, The Journal of Biological Chemistry.

[51]  H. Friess,et al.  The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer , 1999, Oncogene.

[52]  Qiang Zhou,et al.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.

[53]  S. Ishii,et al.  Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. , 1999, Genes & development.

[54]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[55]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[56]  S. Pearson-White,et al.  Proto-oncogene Sno expression, alternative isoforms and immediate early serum response. , 1997, Nucleic acids research.

[57]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[58]  N. Nomura,et al.  Isolation of human cDNA clones of ski and the ski-related gene, sno. , 1989, Nucleic acids research.

[59]  E. Stavnezer,et al.  Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene , 1986, Journal of virology.